Serum Institute of India (SII) CEO Adar Poonawala on Thursday announced the decision to bid for the defending Champions of the Indian Premier League (IPL) Royal Challengers Bengaluru (RCB).
Adar Poonawalla, CEO of Serum Institute of India, has hinted at the prospect of purchasing a stake in the Indian Premier League franchise Royal Challengers Bengaluru (RCB).
Mumbai (Maharashtra) [India], March 5: In a landmark real estate acquisition, the Managing Director of one of India's leading financial institutions has purchased a Rs. 25.5 Cr luxury villa at Avas Living, Alibaug's most sought-after wellness community. With marquee investors like Adar Poona
Mumbai (Maharashtra) [India], February 6: AstaGuru, India's premium auction house, announces a strategic investment from the family office of Adar Poonawalla to acquire approximately 20% stake.
Adar Poonawalla-led Serene Production has entered into an agreement to invest Rs 1,000 crore in Karan Johar's Dharma Productions and Dharmatic Entertainment.
In a major feat, the Serum Institute of India (SII) has shipped its first set of R21/Matrix-M Malaria vaccine doses to the Africa region, which has a sizable disease burden.
Pune (Maharashtra) [India], March 19: Adar Poonawalla said, "Abhay Bhutada spearheaded and was instrumental in successfully transforming the entire company since its acquisition in May 2021. He has strengthened Poonawalla Fincorp with his excellent and extraordinary efforts in less than 3 ye
The world's largest vaccine manufacturer, the Serum Institute of India Private Ltd (SII), is joining a growing Coalition for Epidemic Preparedness Innovations (CEPI) network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future public health
As malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII) has been recommended for use by the World Health Organisation (WHO), SII chief Adar Poonawalla said that the combined efforts of both of them have come to fruition.
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
"As the first conjugate vaccine to safeguard against the five predominant causes of this deadly disease, MenFive® offers hope for a future free from annual outbreaks and epidemics in the African meningitis belt. It is a big moment as we, together, pave the way towards a healthier Africa
Pune (Maharashtra) [India], June 14: Leading digital entertainment and technology company, JetSynthesys, acquires the franchise rights of the 'Ratnagiri Jets' in the highly anticipated fourth edition of the Maharashtra Premier League (MPL) 2023. JetSynthesys won the bid of the team for Rs